APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma-derived Factor VIII

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plasma-derived Factor VIII Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchPlasma-derived Factor VIII Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma-derived Factor VIII Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Plasma-derived Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma-derived Factor VIII Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma-derived Factor VIII Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Plasma-derived Factor VIII market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plasma-derived Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasma-derived Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasma-derived Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasma-derived Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Plasma-derived Factor VIII include Takeda, RAAS, Hualan Bio, Octapharma, Kedrion, Grifols, Greencross, CSL and BPL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plasma-derived Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma-derived Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma-derived Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma-derived Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma-derived Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Plasma-derived Factor VIII sales, projected growth trends, production technology, application and end-user industry.

Plasma-derived Factor VIII Segment by Company

Takeda

RAAS

Hualan Bio

Octapharma

Kedrion

Grifols

Greencross

CSL

BPL

Plasma-derived Factor VIII Segment by Type

200IU

250IU

Plasma-derived Factor VIII Segment by Application

Hospital

Pharmacy

Plasma-derived Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma-derived Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma-derived Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma-derived Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Plasma-derived Factor VIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Plasma-derived Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma-derived Factor VIII sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma-derived Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200IU Major Manufacturers Table 3. 250IU Major Manufacturers Table 4. Global Plasma-derived Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Plasma-derived Factor VIII Industry Trends Table 8. Plasma-derived Factor VIII Industry Drivers Table 9. Plasma-derived Factor VIII Industry Opportunities and Challenges Table 10. Plasma-derived Factor VIII Industry Restraints Table 11. Global Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Plasma-derived Factor VIII Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Plasma-derived Factor VIII Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Plasma-derived Factor VIII Revenue Market Share by Region (2021-2026) Table 15. Global Plasma-derived Factor VIII Revenue Market Share by Region (2027-2032) Table 16. Global Plasma-derived Factor VIII Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 17. Global Plasma-derived Factor VIII Sales by Region (2021-2026) & (units) Table 18. Global Plasma-derived Factor VIII Sales by Region (2027-2032) & (units) Table 19. Global Plasma-derived Factor VIII Sales Market Share by Region (2021-2026) Table 20. Global Plasma-derived Factor VIII Sales Market Share by Region (2027-2032) Table 21. Global Plasma-derived Factor VIII Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Plasma-derived Factor VIII Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2021-2026) Table 25. Global Plasma-derived Factor VIII Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Plasma-derived Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Plasma-derived Factor VIII Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Plasma-derived Factor VIII Manufacturers, Product Type & Application Table 29. Global Plasma-derived Factor VIII Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Plasma-derived Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Plasma-derived Factor VIII Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Plasma-derived Factor VIII Revenue Market Share by Type (2021-2026) Table 36. Global Plasma-derived Factor VIII Revenue Market Share by Type (2027-2032) Table 37. Global Plasma-derived Factor VIII Sales by Type 2021 VS 2025 VS 2032 (units) Table 38. Global Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 39. Global Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 40. Global Plasma-derived Factor VIII Sales Market Share by Type (2021-2026) Table 41. Global Plasma-derived Factor VIII Sales Market Share by Type (2027-2032) Table 42. Global Plasma-derived Factor VIII Price by Type (2021-2026) & (US$/unit) Table 43. Global Plasma-derived Factor VIII Price by Type (2027-2032) & (US$/unit) Table 44. Global Plasma-derived Factor VIII Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Plasma-derived Factor VIII Revenue Market Share by Application (2021-2026) Table 48. Global Plasma-derived Factor VIII Revenue Market Share by Application (2027-2032) Table 49. Global Plasma-derived Factor VIII Sales by Application 2021 VS 2025 VS 2032 (units) Table 50. Global Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 51. Global Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 52. Global Plasma-derived Factor VIII Sales Market Share by Application (2021-2026) Table 53. Global Plasma-derived Factor VIII Sales Market Share by Application (2027-2032) Table 54. Global Plasma-derived Factor VIII Price by Application (2021-2026) & (US$/unit) Table 55. Global Plasma-derived Factor VIII Price by Application (2027-2032) & (US$/unit) Table 56. Takeda Company Information Table 57. Takeda Business Overview Table 58. Takeda Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Takeda Plasma-derived Factor VIII Product Portfolio Table 60. Takeda Recent Development Table 61. RAAS Company Information Table 62. RAAS Business Overview Table 63. RAAS Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. RAAS Plasma-derived Factor VIII Product Portfolio Table 65. RAAS Recent Development Table 66. Hualan Bio Company Information Table 67. Hualan Bio Business Overview Table 68. Hualan Bio Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Hualan Bio Plasma-derived Factor VIII Product Portfolio Table 70. Hualan Bio Recent Development Table 71. Octapharma Company Information Table 72. Octapharma Business Overview Table 73. Octapharma Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Octapharma Plasma-derived Factor VIII Product Portfolio Table 75. Octapharma Recent Development Table 76. Kedrion Company Information Table 77. Kedrion Business Overview Table 78. Kedrion Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Kedrion Plasma-derived Factor VIII Product Portfolio Table 80. Kedrion Recent Development Table 81. Grifols Company Information Table 82. Grifols Business Overview Table 83. Grifols Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Grifols Plasma-derived Factor VIII Product Portfolio Table 85. Grifols Recent Development Table 86. Greencross Company Information Table 87. Greencross Business Overview Table 88. Greencross Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Greencross Plasma-derived Factor VIII Product Portfolio Table 90. Greencross Recent Development Table 91. CSL Company Information Table 92. CSL Business Overview Table 93. CSL Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. CSL Plasma-derived Factor VIII Product Portfolio Table 95. CSL Recent Development Table 96. BPL Company Information Table 97. BPL Business Overview Table 98. BPL Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. BPL Plasma-derived Factor VIII Product Portfolio Table 100. BPL Recent Development Table 101. North America Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 104. North America Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 105. North America Plasma-derived Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Plasma-derived Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 110. North America Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 111. North America Plasma-derived Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Plasma-derived Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Plasma-derived Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Plasma-derived Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 117. North America Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 118. North America Plasma-derived Factor VIII Sales by Country (2027-2032) & (units) Table 119. North America Plasma-derived Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Plasma-derived Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 122. Canada Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 123. Mexico Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 124. Europe Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 127. Europe Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 128. Europe Plasma-derived Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Plasma-derived Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 133. Europe Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 134. Europe Plasma-derived Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Plasma-derived Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Plasma-derived Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Plasma-derived Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 140. Europe Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 141. Europe Plasma-derived Factor VIII Sales by Country (2027-2032) & (units) Table 142. Europe Plasma-derived Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Plasma-derived Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 145. France Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 146. U.K. Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 147. Italy Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 148. Russia Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 149. Spain Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 152. Sweden Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 153. Poland Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 154. China Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 155. China Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 156. China Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 157. China Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 158. China Plasma-derived Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Plasma-derived Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 161. China Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 162. China Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 163. China Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 164. China Plasma-derived Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Plasma-derived Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 169. Asia Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 170. Asia Plasma-derived Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Plasma-derived Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 175. Asia Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 176. Asia Plasma-derived Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Plasma-derived Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Plasma-derived Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Plasma-derived Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 182. Asia Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 183. Asia Plasma-derived Factor VIII Sales by Country (2027-2032) & (units) Table 184. Asia Plasma-derived Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Plasma-derived Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 187. South Korea Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 188. India Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 189. Australia Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Plasma-derived Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Plasma-derived Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 195. SAMEA Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 196. SAMEA Plasma-derived Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Plasma-derived Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Plasma-derived Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Plasma-derived Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 201. SAMEA Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 202. SAMEA Plasma-derived Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Plasma-derived Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Plasma-derived Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Plasma-derived Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 208. SAMEA Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 209. SAMEA Plasma-derived Factor VIII Sales by Country (2027-2032) & (units) Table 210. SAMEA Plasma-derived Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Plasma-derived Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 213. Argentina Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 214. Chile Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 215. Colombia Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 216. Peru Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 218. Israel Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 219. UAE Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 220. Turkey Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 221. Iran Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 222. Egypt Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Plasma-derived Factor VIII Distributors List Table 226. Plasma-derived Factor VIII Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Plasma-derived Factor VIII Image Figure 2. Global Plasma-derived Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma-derived Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200IU Image Figure 5. 250IU Image Figure 6. Global Plasma-derived Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plasma-derived Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Plasma-derived Factor VIII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Plasma-derived Factor VIII Revenue (2021-2032) & (US$ Million) Figure 12. Global Plasma-derived Factor VIII Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Plasma-derived Factor VIII Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Plasma-derived Factor VIII Revenue Market Share by Region (2021-2032) Figure 15. Global Plasma-derived Factor VIII Sales (2021-2032) & (units) Figure 16. Global Plasma-derived Factor VIII Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Plasma-derived Factor VIII Sales YoY (2021-2032) & (units) Figure 19. Europe Plasma-derived Factor VIII Sales YoY (2021-2032) & (units) Figure 20. China Plasma-derived Factor VIII Sales YoY (2021-2032) & (units) Figure 21. Asia (Excluding China) Plasma-derived Factor VIII Sales YoY (2021-2032) & (units) Figure 22. South America, Middle East and Africa Plasma-derived Factor VIII Sales YoY (2021-2032) & (units) Figure 23. Global Plasma-derived Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Plasma-derived Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Plasma-derived Factor VIII Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Plasma-derived Factor VIII Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Plasma-derived Factor VIII Revenue Market Share by Type (2021-2032) Figure 29. Global Plasma-derived Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 30. Global Plasma-derived Factor VIII Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Plasma-derived Factor VIII Sales Market Share by Type (2021-2032) Figure 32. Global Plasma-derived Factor VIII Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Plasma-derived Factor VIII Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Plasma-derived Factor VIII Revenue Market Share by Application (2021-2032) Figure 35. Global Plasma-derived Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 36. Global Plasma-derived Factor VIII Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Plasma-derived Factor VIII Sales Market Share by Application (2021-2032) Figure 38. North America Plasma-derived Factor VIII Revenue Share by Type (2021-2032) Figure 39. North America Plasma-derived Factor VIII Sales Share by Type (2021-2032) Figure 40. North America Plasma-derived Factor VIII Revenue Share by Application (2021-2032) Figure 41. North America Plasma-derived Factor VIII Sales Share by Application (2021-2032) Figure 42. North America Plasma-derived Factor VIII Revenue Share by Country (2021-2032) Figure 43. North America Plasma-derived Factor VIII Sales Share by Country (2021-2032) Figure 44. Europe Plasma-derived Factor VIII Revenue Share by Type (2021-2032) Figure 45. Europe Plasma-derived Factor VIII Sales Share by Type (2021-2032) Figure 46. Europe Plasma-derived Factor VIII Revenue Share by Application (2021-2032) Figure 47. Europe Plasma-derived Factor VIII Sales Share by Application (2021-2032) Figure 48. Europe Plasma-derived Factor VIII Revenue Share by Country (2021-2032) Figure 49. Europe Plasma-derived Factor VIII Sales Share by Country (2021-2032) Figure 50. China Plasma-derived Factor VIII Revenue Share by Type (2021-2032) Figure 51. China Plasma-derived Factor VIII Sales Share by Type (2021-2032) Figure 52. China Plasma-derived Factor VIII Revenue Share by Application (2021-2032) Figure 53. China Plasma-derived Factor VIII Sales Share by Application (2021-2032) Figure 54. Asia Plasma-derived Factor VIII Revenue Share by Type (2021-2032) Figure 55. Asia Plasma-derived Factor VIII Sales Share by Type (2021-2032) Figure 56. Asia Plasma-derived Factor VIII Revenue Share by Application (2021-2032) Figure 57. Asia Plasma-derived Factor VIII Sales Share by Application (2021-2032) Figure 58. Asia Plasma-derived Factor VIII Revenue Share by Country (2021-2032) Figure 59. Asia Plasma-derived Factor VIII Sales Share by Country (2021-2032) Figure 60. SAMEA Plasma-derived Factor VIII Revenue Share by Type (2021-2032) Figure 61. SAMEA Plasma-derived Factor VIII Sales Share by Type (2021-2032) Figure 62. SAMEA Plasma-derived Factor VIII Revenue Share by Application (2021-2032) Figure 63. SAMEA Plasma-derived Factor VIII Sales Share by Application (2021-2032) Figure 64. SAMEA Plasma-derived Factor VIII Revenue Share by Country (2021-2032) Figure 65. SAMEA Plasma-derived Factor VIII Sales Share by Country (2021-2032) Figure 66. Plasma-derived Factor VIII Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Plasma-derived Factor VIII Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 250IU
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Takeda
  • RAAS
  • Hualan Bio
  • Octapharma
  • Kedrion
  • Grifols
  • Greencross
  • CSL
  • BPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma-derived Factor VIII Market by Type
  3. 1.2.1 Global Plasma-derived Factor VIII Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200IU
  5. 1.2.3 250IU
  6. 1.3 Plasma-derived Factor VIII Market by Application
  7. 1.3.1 Global Plasma-derived Factor VIII Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Plasma-derived Factor VIII Market Dynamics
  1. 2.1 Plasma-derived Factor VIII Industry Trends
  2. 2.2 Plasma-derived Factor VIII Industry Drivers
  3. 2.3 Plasma-derived Factor VIII Industry Opportunities and Challenges
  4. 2.4 Plasma-derived Factor VIII Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Plasma-derived Factor VIII Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Plasma-derived Factor VIII Revenue by Region
  3. 3.2.1 Global Plasma-derived Factor VIII Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma-derived Factor VIII Revenue by Region (2021-2026)
  5. 3.2.3 Global Plasma-derived Factor VIII Revenue by Region (2027-2032)
  6. 3.2.4 Global Plasma-derived Factor VIII Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Plasma-derived Factor VIII Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Plasma-derived Factor VIII Sales by Region
  9. 3.4.1 Global Plasma-derived Factor VIII Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Plasma-derived Factor VIII Sales by Region (2021-2026)
  11. 3.4.3 Global Plasma-derived Factor VIII Sales by Region (2027-2032)
  12. 3.4.4 Global Plasma-derived Factor VIII Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Plasma-derived Factor VIII Revenue by Manufacturers
  2. 4.1.1 Global Plasma-derived Factor VIII Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Plasma-derived Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma-derived Factor VIII Sales by Manufacturers
  6. 4.2.1 Global Plasma-derived Factor VIII Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Plasma-derived Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Plasma-derived Factor VIII Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Plasma-derived Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Plasma-derived Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Plasma-derived Factor VIII Manufacturers, Product Type & Application
  13. 4.7 Global Plasma-derived Factor VIII Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Plasma-derived Factor VIII Market CR5 and HHI
  16. 4.8.2 2025 Plasma-derived Factor VIII Tier 1, Tier 2, and Tier 3
5 Plasma-derived Factor VIII Market by Type
  1. 5.1 Global Plasma-derived Factor VIII Revenue by Type
  2. 5.1.1 Global Plasma-derived Factor VIII Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Plasma-derived Factor VIII Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Plasma-derived Factor VIII Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Plasma-derived Factor VIII Sales by Type
  6. 5.2.1 Global Plasma-derived Factor VIII Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma-derived Factor VIII Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Plasma-derived Factor VIII Sales Market Share by Type (2021-2032)
  9. 5.3 Global Plasma-derived Factor VIII Price by Type
6 Plasma-derived Factor VIII Market by Application
  1. 6.1 Global Plasma-derived Factor VIII Revenue by Application
  2. 6.1.1 Global Plasma-derived Factor VIII Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Plasma-derived Factor VIII Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Plasma-derived Factor VIII Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Plasma-derived Factor VIII Sales by Application
  6. 6.2.1 Global Plasma-derived Factor VIII Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Plasma-derived Factor VIII Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Plasma-derived Factor VIII Sales Market Share by Application (2021-2032)
  9. 6.3 Global Plasma-derived Factor VIII Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Plasma-derived Factor VIII Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 RAAS
  8. 7.2.1 RAAS Company Information
  9. 7.2.2 RAAS Business Overview
  10. 7.2.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 RAAS Plasma-derived Factor VIII Product Portfolio
  12. 7.2.5 RAAS Recent Developments
  13. 7.3 Hualan Bio
  14. 7.3.1 Hualan Bio Company Information
  15. 7.3.2 Hualan Bio Business Overview
  16. 7.3.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hualan Bio Plasma-derived Factor VIII Product Portfolio
  18. 7.3.5 Hualan Bio Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Plasma-derived Factor VIII Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Kedrion
  26. 7.5.1 Kedrion Company Information
  27. 7.5.2 Kedrion Business Overview
  28. 7.5.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kedrion Plasma-derived Factor VIII Product Portfolio
  30. 7.5.5 Kedrion Recent Developments
  31. 7.6 Grifols
  32. 7.6.1 Grifols Company Information
  33. 7.6.2 Grifols Business Overview
  34. 7.6.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Grifols Plasma-derived Factor VIII Product Portfolio
  36. 7.6.5 Grifols Recent Developments
  37. 7.7 Greencross
  38. 7.7.1 Greencross Company Information
  39. 7.7.2 Greencross Business Overview
  40. 7.7.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Greencross Plasma-derived Factor VIII Product Portfolio
  42. 7.7.5 Greencross Recent Developments
  43. 7.8 CSL
  44. 7.8.1 CSL Company Information
  45. 7.8.2 CSL Business Overview
  46. 7.8.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CSL Plasma-derived Factor VIII Product Portfolio
  48. 7.8.5 CSL Recent Developments
  49. 7.9 BPL
  50. 7.9.1 BPL Company Information
  51. 7.9.2 BPL Business Overview
  52. 7.9.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BPL Plasma-derived Factor VIII Product Portfolio
  54. 7.9.5 BPL Recent Developments
8 North America
  1. 8.1 North America Plasma-derived Factor VIII Market Size by Type
  2. 8.1.1 North America Plasma-derived Factor VIII Revenue by Type (2021-2032)
  3. 8.1.2 North America Plasma-derived Factor VIII Sales by Type (2021-2032)
  4. 8.1.3 North America Plasma-derived Factor VIII Price by Type (2021-2032)
  5. 8.2 North America Plasma-derived Factor VIII Market Size by Application
  6. 8.2.1 North America Plasma-derived Factor VIII Revenue by Application (2021-2032)
  7. 8.2.2 North America Plasma-derived Factor VIII Sales by Application (2021-2032)
  8. 8.2.3 North America Plasma-derived Factor VIII Price by Application (2021-2032)
  9. 8.3 North America Plasma-derived Factor VIII Market Size by Country
  10. 8.3.1 North America Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Plasma-derived Factor VIII Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Plasma-derived Factor VIII Market Size by Type
  2. 9.1.1 Europe Plasma-derived Factor VIII Revenue by Type (2021-2032)
  3. 9.1.2 Europe Plasma-derived Factor VIII Sales by Type (2021-2032)
  4. 9.1.3 Europe Plasma-derived Factor VIII Price by Type (2021-2032)
  5. 9.2 Europe Plasma-derived Factor VIII Market Size by Application
  6. 9.2.1 Europe Plasma-derived Factor VIII Revenue by Application (2021-2032)
  7. 9.2.2 Europe Plasma-derived Factor VIII Sales by Application (2021-2032)
  8. 9.2.3 Europe Plasma-derived Factor VIII Price by Application (2021-2032)
  9. 9.3 Europe Plasma-derived Factor VIII Market Size by Country
  10. 9.3.1 Europe Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Plasma-derived Factor VIII Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Plasma-derived Factor VIII Market Size by Type
  2. 10.1.1 China Plasma-derived Factor VIII Revenue by Type (2021-2032)
  3. 10.1.2 China Plasma-derived Factor VIII Sales by Type (2021-2032)
  4. 10.1.3 China Plasma-derived Factor VIII Price by Type (2021-2032)
  5. 10.2 China Plasma-derived Factor VIII Market Size by Application
  6. 10.2.1 China Plasma-derived Factor VIII Revenue by Application (2021-2032)
  7. 10.2.2 China Plasma-derived Factor VIII Sales by Application (2021-2032)
  8. 10.2.3 China Plasma-derived Factor VIII Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma-derived Factor VIII Market Size by Type
  2. 11.1.1 Asia Plasma-derived Factor VIII Revenue by Type (2021-2032)
  3. 11.1.2 Asia Plasma-derived Factor VIII Sales by Type (2021-2032)
  4. 11.1.3 Asia Plasma-derived Factor VIII Price by Type (2021-2032)
  5. 11.2 Asia Plasma-derived Factor VIII Market Size by Application
  6. 11.2.1 Asia Plasma-derived Factor VIII Revenue by Application (2021-2032)
  7. 11.2.2 Asia Plasma-derived Factor VIII Sales by Application (2021-2032)
  8. 11.2.3 Asia Plasma-derived Factor VIII Price by Application (2021-2032)
  9. 11.3 Asia Plasma-derived Factor VIII Market Size by Country
  10. 11.3.1 Asia Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Plasma-derived Factor VIII Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma-derived Factor VIII Market Size by Type
  2. 12.1.1 SAMEA Plasma-derived Factor VIII Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Plasma-derived Factor VIII Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Plasma-derived Factor VIII Price by Type (2021-2032)
  5. 12.2 SAMEA Plasma-derived Factor VIII Market Size by Application
  6. 12.2.1 SAMEA Plasma-derived Factor VIII Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Plasma-derived Factor VIII Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Plasma-derived Factor VIII Price by Application (2021-2032)
  9. 12.3 SAMEA Plasma-derived Factor VIII Market Size by Country
  10. 12.3.1 SAMEA Plasma-derived Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Plasma-derived Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Plasma-derived Factor VIII Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Plasma-derived Factor VIII Value Chain Analysis
  2. 13.1.1 Plasma-derived Factor VIII Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Plasma-derived Factor VIII Production Mode & Process
  6. 13.2 Plasma-derived Factor VIII Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Plasma-derived Factor VIII Distributors
  9. 13.2.3 Plasma-derived Factor VIII Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst